# |
PMID |
Sentence |
1 |
18285412
|
Our objective was to investigate the impact of rs7754840 of CDKAL1 on insulin secretion, insulin sensitivity, and risk of type 2 diabetes.
|
2 |
18285412
|
In study 2, rs7754840 was significantly associated with type 2 diabetes (P = 0.022) and markers of impaired insulin release [insulinogenic index (IGI), P = 0.012] in 2405 men with normal glucose tolerance. rs7754840 of CDKAL1 was associated with markers of impaired insulin secretion in two independent studies.
|
3 |
18285412
|
Therefore, CDKAL1 is likely to increase the risk of type 2 diabetes by impairing insulin secretion.
|
4 |
19258404
|
In our cohort, only polymorphisms in SLC30A8, HHEX, TCF7L2, and CDKAL1 influenced insulin secretion.
|
5 |
19622614
|
The fetal insulin hypothesis proposes that common genetic variants that reduce insulin secretion also reduce birth weight, and an association of low birth weight and the type 2 diabetes risk alleles at the HHEX-IDE and CDKAL1 loci were recently reported.
|
6 |
21151568
|
A variant of the CDKAL1 gene was reported to be associated with type 2 diabetes and reduced insulin release in humans; however, the role of CDKAL1 in ? cells is largely unknown.
|
7 |
21151568
|
Our results indicate that CDKAL1 controls first-phase insulin exocytosis in ? cells by facilitating ATP generation, K(ATP) channel responsiveness and the subsequent activity of Ca(2+) channels through pathways other than CDK5-mediated regulation.
|
8 |
21841312
|
Mice with pancreatic ? cell-specific KO of Cdkal1 (referred to herein as ? cell KO mice) showed pancreatic islet hypertrophy, a decrease in insulin secretion, and impaired blood glucose control.
|